IP Library Granted Patent US 8,299,302
Granted Patent B2
US 8,299,302 · App. 12/530,777 · Granted Oct 30, 2012

4-Cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides

Assignee: Bayer Cropscience AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,299,302
App. No.
12/530,777
Granted
Oct 30, 2012
Kind
B2
Abstract

The present invention relates to 4-cycloalkyl- or 4-aryl-substituted phenoxyphenylamidines of the general formula (I), to a process for their preparation, to the use of the amidines according to the invention for controlling unwanted microorganisms and also to a composition for this purpose, comprising the phenoxyphenylamidines according to the invention. Furthermore, the invention relates to a method for controlling unwanted microorganisms by applying the compounds according to the invention to the microorganisms and/or their habitat.

Claims (31)

1. A 4-cycloalkyl- or 4-aryl-substituted phenoxyphenylamidine of the formula (I)

in which

R 1 is selected from the group consisting of hydrogen and methyl;

R 2 is selected from the group consisting of methyl and ethyl;

R 3 is selected from the group consisting of ethyl and cyclopropyl;

or where

R 2 and R 3 together with the nitrogen atom to which they are attached form a piperidyl or pyrrolidyl radical;

R 4 and R 5 independently of one another are selected from the group consisting of Cl and F atoms and —CF 3 , —CF 2 H and methyl groups;

R 6 is, independently of R 7 , selected from the group consisting of hydrogen, —CF 3 , and —CHF 2 ;

R 7 is selected from the group consisting of phenyl, 4-chlorophenol, 4-ethylsulfonylphenyl, 4-trifluoromethylphenyl, 4-dimethylaminophenyl, 4-methoxyphenyl, 4-tert-butylphenyl, 4-acetylphenyl, 4-fluorophenyl, 2-ethylphenyl, 2-trifluoromethylphenyl, 2-isopropylphenyl, 2-methylphenyl, 2-fluorophenyl, 2-acetylphenol, 2-methoxyphenyl, 2-chlorophenol, 2-(2-methylpropoxy)-phenyl, cyclopropyl, cyclohexyl, cycloheptyl, cyclooctyl;

and/or a salt.

2. The 4-cycloalkyl- or 4-aryl-substituted phenoxyphenylamidine as claimed in claim 1 selected from the group consisting of N′-{4-[(4′-chlorobiphenyl-4-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide (1), N-ethyl-N′-(4-{[4′-(ethylsulfonyl)biphenyl-4-yl]oxy}-2,5-dimethylphenyl)-N-methylimidoformamide (2), N′-(2,5-dimethyl-4-{[4′-(trifluoromethyl)biphenyl-4-yl]oxy}phenyl)-N-ethyl-N-methylimidoformamide (3), N′-(4-{[4′-(dimethylamino)biphenyl-4-yl]oxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide (4), N-ethyl-N′-{4-[(4′-methoxybiphenyl-4-yl)oxy]-2,5-dimethylphenyl}-N-methylimidoformamide (5), N′-(2,5-dimethyl-4-{[4′-(methylthio)biphenyl-4-yl]oxy}phenyl)-N-ethyl-N-methylimidoformamide (6), N′-(2,5-dimethyl-4-{[4′-(tert-butyl)biphenyl-4-yl]oxy}phenyl)-N-ethyl-N-methylimidoformamide (7), N′-{4-[(4′-acetylbiphenyl-4-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide (8), N′-[4-({4′-[(E)-(butoxyimino)methyl]biphenyl-4-yl}methyl)-2,5-dimethylphenyl]-N-ethyl-N-methylimidoformamide (10), N-ethyl-N′-{4-[(4′-fluorobiphenyl-4-yl)methyl]-2,5-dimethylphenyl}-N-methylimidoformamide (11), N-ethyl-N′-[4-({4′-[(E)-(methoxyimino)methyl]biphenyl-4-yl}methyl)-2,5-dimethylphenyl]-N-methylimidoformamide (12), N-ethyl-N′-{4-[(2′-ethylbiphenyl-4-yl)methyl]-2,5-dimethylphenyl}-N-methylimidoformamide (13) N′-(2,5-dimethyl-4-{[2′-(trifluoromethyl)biphenyl-4-yl]methyl}phenyl)-N-ethyl-N-methylimidoformamide (14), N-ethyl-N′-{4-[(2′-isopropylbiphenyl-4-yl)methyl]-2,5-dimethylphenyl}-N-methylimidoformamide (15), N-ethyl-N′-{4-[(2′-methylbiphenyl-4-yl)methyl]-2,5-dimethylphenyl}-N-methylimidoformamide (16), N-ethyl-N′-{4-[(2′-fluorobiphenyl-4-yl)methyl]-2,5-dimethylphenyl}-N-methylimidoformamide (17), N′-{4-[(2′-acetylbiphenyl-4-yl)methyl]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide (18), N′-{4-[(2′-methoxybiphenyl-4-yl)methyl]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide (19), 2,5-dimethyl-N-[(1E)-piperidin-1-ylmethylene]-4-{[2′-(trifluoromethyl)biphenyl-4-yl]methyl}aniline (20), 2,5-dimethyl-N-[(1E)-piperidin-1-ylmethylene]-4-{[2′-fluorobiphenyl-4-yl]methyl}aniline (21), 2,5-dimethyl-N-[(1E)-piperidin-1-ylmethylene]-4-{[2′-acetylbiphenyl-4-yl]methyl}aniline (22), 2,5-dimethyl-N-[(1E)-piperidin-1-ylmethylene]-4-{[2′-ethylbiphenyl-4-yl]methyl}aniline (23), 2,5-dimethyl-N-[(1E)-piperidin-1-ylmethylene]-4-{[2′-methylbiphenyl-4-yl]methyl}aniline (24), 2,5-dimethyl-N-[(1E)-piperidin-1-ylmethylene]-4-{[2′-isopropylbiphenyl-4-yl]methyl}aniline (25), 2,5-dimethyl-N-[(1E)-piperidin-1-ylmethylene]-4-{[2′-chlorobiphenyl-4-yl]-methyl}aniline (26), N′-{4-[(2′-chlorobiphenyl-4-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide (27), 4-[(2′-isobutoxybiphenyl-4-yl)oxy]-2,5-dimethyl-N-[(1E)-piperidin-1-ylmethylene]aniline (28), N-ethyl-N′-{4-[(2′-isobutoxybiphenyl-4-yl)oxy]-2,5-dimethylphenyl}-N-methylimidoformamide (29), 4-[(4′-fluorobiphenyl-4-yl)oxy]-2,5-dimethyl-N-[(1E)-pyrrolidin-1-ylmethylene]aniline (30), N′-[4-(biphenyl-4-yloxy)-2,5-dimethylphenyl]-N-ethyl-N-methylimidoformamide (31), N′-[4-(4-cyclopentylphenoxy)-2,5-dimethylphenyl]-N-ethyl-N-methylimidoformamide (32), N′-[4-(4-cyclopentylphenoxy)-2,5-dimethylphenyl]-N-isopropyl-N-methylimidoformamide (33), 4-(4-cyclopentylphenoxy)-2,5-dimethyl-N-[(1E)-(2-methylpiperidin-1-yl)methylene]aniline (34), 4-(4-cyclopentylphenoxy)-2,5-dimethyl-N-[(1E)-piperidin-1-ylmethylene]-aniline (35), N′-[4-(2-chloro-4-cyclopentylphenoxy)-2,5-dimethylphenyl]-N-ethyl-N-methylimidoformamide (36), N′-{4-[4-cyclopentyl-2-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide (37), N′-{4-[4-cyclohexylphenoxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide (38), N′-{4-[4-cyclohexylphenoxy]-2,5-dimethylphenyl}-N-isopropyl-N-methylimidoformamide (39), N′-{4-[4-cyclohexyl-2-phenoxy]-2,5-dimethylphenyl}-N-[(1E)-(2-methylpiperidin-1-yl)methylene]aniline (40), 4-(4-cyclohexylphenoxy)-2,5-dimethyl-N-[(1E)-piperidin-1-ylmethylene]aniline (41) and N′-{4-[4-cyclohexyl-2-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide (42).

3. A composition for controlling unwanted microorganisms, comprising at least one phenoxyphenylamidine and/or a salt thereof as claimed in claim 1 .

4. A method for controlling unwanted microorganisms, comprising applying a 4-cycloalkyl- or 4-aryl-substituted phenoxyphenylamidine and/or a salt thereof as claimed in claim 1 to the microorganisms and/or a habitat thereof.

5. Seed treated with at least one 4-cycloalkyl- or 4-aryl-substituted phenoxyphenylamidine and/or a salt thereof as claimed in claim 1 .

6. A method for treating seed, transgenic plants or seed of transgenic plants comprising applying at least one 4-cycloalkyl- or 4-aryl-substituted phenoxyphenylamidine and/or a salt thereof as claimed in claim 1 to the seed, transgenic plants or seed of transgenic plants.

7. A method for protecting seed against unwanted microorganisms comprising applying at least one 4-cycloalkyl- or 4-aryl-substituted phenoxyphenylamidine and/or a salt thereof as claimed in claim 1 to the seed.

8. The 4-cycloalkyl- or 4-aryl-substituted phenoxyphenylamidine as claimed in claim 1 where

R 2 is methyl; and

R 3 is ethyl.

9. A composition of claim 3 , wherein the composition comprises between 0.1% and 95% by weight of at least one phenoxyphenylamidine and/or a salt.

10. The 4-cycloalkyl- or 4-aryl-substituted phenoxyphenylamidine as claimed in claim 1 where

R 6 is hydrogen.

11. The 4-cycloalkyl- or 4-aryl-substituted phenoxyphenylamidine as claimed in claim 1 where

R 1 is hydrogen;

R 2 is ethyl;

R 3 is methyl;

R 4 is methyl;

R 5 is methyl;

R 6 is hydrogen; and

R 7 is phenyl.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 034891 FRAME: 0140. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 19, 2015
From: BAYER CROPSCIENCE AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 035046/0921 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2015
From: BAYER CROPSCIENCE AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 034891/0140 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2009
From: KUNZ, KLAUS, DR.; DUNKEL, RALF, DR.; GREUL, JOERG NICO, DR.; GUTH, OLIVER, DR.; ILG, KERSTIN, DR.; MANSFIELD, DARRIN JAMES, DR.; MORADI, WAHED AHMED, DR.; SEITZ, THOMAS, DR.; DAHMEN, PETER, DR.; WACHENDORFF-NEUMANN, ULRIKE, DR.; VOERSTE, ARND, DR.; VORS, JEAN-PIERRE, DR.
To: BAYER CROPSCIENCE AG
Reel/Frame 023362/0470 →
Priority Claims (1)
EP 07005005 · Mar 12, 2007 · regional
Continuity (1)
Related Publication 20100120615A1 · May 13, 2010